Comparison of the pharmacokinetics of donafenib and sorafenib in patients with advanced hepatocellular carcinoma: An open-label, randomized, parallel-controlled, multicentre phase II/III trial

S. Qin, F. Bi,J. Xu, C. Du, Q. Fan,L. Zhang,M. Tao, D. Jiang,S. Wang,Y. Chen,J. Sheng, X. Zhuang,J. Wu, B. Lv

Annals of Oncology(2020)

引用 2|浏览42
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要